AstraZeneca Faces Double Whammy: China Probe and Lawsuit by Hagens Berman Amidst Swirling Scandals
AstraZeneca’s Tumultuous Six Months: Allegations and Consequences Over the past six months, AstraZeneca (AZN), a leading pharmaceutical company with Anglo-Swedish roots, has experienced a significant setback. The stock price has plummeted by an alarming 15 percent, leaving investors and analysts questioning the company’s future. This downturn can be attributed to a series of unsettling reports…